CD8⁺ Foxp3⁺ T Cells Affect Alveolar Bone Homeostasis via Modulating Tregs/Th17 During Induced Periodontitis: an...

Area of Science:

• Immunology
• Oral Biology
• Bone Biology

Background:

• Periodontitis is a complex disease involving dysbiotic bacteria, inflammation, and alveolar bone destruction.
• The precise mechanisms of inflammation-mediated bone loss in periodontitis require further elucidation.
• The role of CD8+ regulatory T cells (CD8+ Tregs) in maintaining alveolar bone homeostasis during periodontitis is not well understood.

Purpose of the Study:

• To investigate the function of CD8+ Tregs in regulating alveolar bone homeostasis during periodontitis.
• To explore the underlying mechanisms by which CD8+ Tregs influence bone destruction and immune responses in periodontitis.

Main Methods:

• Analysis of CD8+ Treg presence in healthy and periodontitis animal models.
• Establishment of an adoptive transfer model using CD8+ Tregs from periodontitis animals.
• Induction of experimental periodontitis and assessment of alveolar bone loss and osteoclast formation.
• Quantification of immune cell populations (CD8+ Tregs, CD4+ T cells, CD4+ Tregs, Th17 cells) and cytokine expression (IL-1β, IL-6, IL-10, IL-17A, RANKL, TGF-β) in relevant tissues.

Main Results:

• Periodontitis did not significantly alter the proportion or amount of CD8+ Tregs.
• Adoptive transfer of CD8+ Tregs effectively reduced alveolar bone destruction and osteoclast formation.
• Periodontitis increased Th17 cells and decreased CD4+ Tregs in the gingiva and lymph nodes.
• Cytokine profiles shifted towards pro-inflammatory mediators (IL-1β, IL-6, IL-17A, RANKL) and away from anti-inflammatory ones (IL-10, TGF-β) in periodontitis, with CD8+ Treg transfer reversing these changes.

Conclusions:

• CD8+ Tregs play a protective role in maintaining alveolar bone homeostasis during periodontitis.
• These cells exert their protective effects by suppressing osteoclastogenesis and modulating local immune responses.
• CD8+ Tregs represent a potential therapeutic target for periodontitis treatment.